Cancer Treatment: Paclitaxel is used in the treatment of various cancers, including breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and others. It works by interfering with the growth and division of cancer cells, ultimately leading to their death.
Mechanism of Action: Paclitaxel belongs to a class of medications known as taxanes. It works by stabilizing microtubules in cancer cells, preventing their breakdown during cell division. This disruption of microtubule dynamics inhibits mitosis (cell division), ultimately leading to cell death.
Combination Therapy: Paclitaxel is often used in combination with other chemotherapy drugs or as part of multi-drug regimens to enhance its effectiveness in treating cancer. Combinations may vary depending on the type and stage of cancer being treated.
Administration: Paclitaxel is typically administered intravenously (IV) in a clinical setting, either as a standalone treatment or as part of a chemotherapy regimen. It is usually given over several hours, and the frequency and dosage depend on factors such as the type of cancer, the patient's overall health, and the treatment protocol.
Side Effects: Common side effects of paclitaxel chemotherapy may include:
Nausea and vomiting
Fatigue
Hair loss (alopecia)
Bone marrow suppression (leading to decreased white blood cells, red blood cells, and platelets)
Peripheral neuropathy (numbness, tingling, or pain in the hands and feet)
Muscle or joint pain
Mouth sores
Changes in taste or appetite
Nail changes
Allergic reactions (rare but possible)
Neutropenia: One of the significant side effects of paclitaxel is neutropenia, a decrease in the number of neutrophils (a type of white blood cell) in the bloodstream. Neutropenia increases the risk of infections and requires close monitoring during treatment.
Hypersensitivity Reactions: Some individuals may experience hypersensitivity reactions to paclitaxel, particularly during the first infusion. Symptoms may include fever, chills, rash, itching, difficulty breathing, or low blood pressure. Pre-treatment with corticosteroids, antihistamines, and H2-receptor antagonists may help prevent such reactions.
Cardiotoxicity: Paclitaxel has been associated with potential cardiotoxicity, including arrhythmias, myocardial infarction, and heart failure, particularly in patients with pre-existing cardiac conditions or those receiving high doses of the medication.
Pregnancy and Breastfeeding: Paclitaxel is contraindicated during pregnancy due to its potential for causing fetal harm. It may also pass into breast milk and pose risks to breastfeeding infants. Women of childbearing potential should use effective contraception during paclitaxel treatment and avoid breastfeeding.
Monitoring: Patients receiving paclitaxel chemotherapy require close monitoring of blood counts, liver function tests, kidney function, and cardiac function throughout treatment. Dose adjustments or treatment modifications may be necessary based on individual patient factors and treatment response.
Long-term Effects: Paclitaxel treatment may have long-term effects on various organ systems, including the nervous system, cardiovascular system, and bone marrow. Regular follow-up care and monitoring are essential to detect and manage any potential late effects of treatment.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
Impact of paclitaxel,(prescription) on Conditions from US National Library of Medicine
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups.
We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio: Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
This is an Academic site. It generates
theoretical models
of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]
